The newest list price for Pfizer’s Paxlovid, the life-saving antiviral drug used to reduce the risk of COVID-19, which is more than double its previous cost of $530. A nonprofit drug-pricing watchdog estimated the cost-effectiveness analysis last year of Paxlovid at between $563 and $906 per treatment course.
